日本再生医療学会

機関誌

再生医療

日本再生医療学会雑誌「再生医療」は普通の学会誌とは異なり、掲載内容が多岐に亘りユニークです。これは、学会編集委員と出版社編集担当者との話し合いから作られる学会誌と商業誌のハイブリッド誌だからです。加えて、この研究領域が医歯工薬理学の融合を必要とし、その研究成果の治療応用という企業化を含んでいるからです。

再生医療分野で知っておくべきテーマ、最先端の内容について、それぞれの分野の第一人者に執筆をお願いするとともに、研究、企業、規制の現状をわかりやすく把握できる解説、国内外研究、再生医療企業、および最新研究成果に関する情報をリアルタイムでお知らせしています。そんな手作りの雑誌「再生医療」は、バイオエンジニアリング(医工学、組織工学)、ライフサイエンス、メディカルに興味ある方なら誰でもワクワクして手に取って読みたくなる雑誌です。

  • 再生医療分野の最先端トピックスの紹介
  • 再生医療の実用化、規制、企業のなまの情報の提供
  • 最新の国内外研究情報を迅速に紹介
  • 再生医療の実用化、規制、企業の現場の情報の提供

REGENERATIVE THERAPY

Regenerative Therapy is the official peer-reviewed online journal of the Japanese Society for Regenerative Medicine. Regenerative Therapy is a multidisciplinary journal that publishes original articles and reviews of basic research, clinical translation, industrial development, and regulatory issues focusing on stem cell biology, tissue engineering, and regenerative medicine.(Impact Factor: 4.3)

A Message from the Editor-in-Chief

I am delighted to celebrate the launch of Regenerative Therapy, a new multidisciplinary, peer-reviewed journal that publishes original research in stem cell biology, tissue engineering, and regenerative medicine.
Regenerative therapies provide innovative approaches to deliver revolutionary cell-based products that could treat a range of debilitating diseases, which cannot be treated with conventional medicine. The primary goal of our endeavor is to implement suitable treatments to our patients as rapidly and as safely as possible.

Regenerative Therapy is a journal for all players pursuing this endeavor in the arena of regenerative medicine. It provides an important forum to address critical issues in the field, exchange new ideas and disseminate the latest developments in basic research, clinical translation, industrial development and regulatory issues focusing on tissue engineering, regenerative therapy, stem cell biology and cell engineering. Regenerative Therapy plays a valuable role in accumulating scientific data and promoting science-based industrial development and harmonization of regulatory issues for cell-based products. The journal also explores ethical, legal, and social perspectives on regenerative medicine.

We hope Regenerative Therapy will become the primary platform for researchers to share findings and discuss all aspects of regenerative therapy in the development of future innovations that will benefit the international community. We are now welcoming submissions for future issues of the journal. Together, let’s make regenerative therapy happen.

Ung-il Chung, MD, PhD
Editor-in-Chief
Regenerative Therapy